1. Beckmann MW, Fasching PA, Lux MP, Klemt D, Schroer B, Bodden-Heidrich R, Goecke TO, Niederacher D, Nestle-Krämling C (2001) Das familiäre Mammakarzinom-Syndrom: Prädiktive genetische Testung, Beratung und Betreuung. Med Welt 52:385–390
2. Easton DF (2002) Familial risks of breast cancer. Breast Cancer Res 4(5):179–181
3. Boyd J (2001) Molecular genetics of hereditary ovarian cancer. In: Rubin SC, Sutton GP (eds) Ovarian cancer, vol 2. Lippincott Williams & Wilkins, Philadelphia, pp 3–17
4. Lux MP, Fasching P, Ackermann S, Bani M, Nestle-Kraemling C, Goecke TO, Niederacher D, Bodden-Heidrich R, Bender HG, Beckmann MW (2005) Age of uptake of early cancer detection facilities by low-risk and high-risk patients with familial breast and ovarian cancer. Eur J Cancer Prev (in press)
5. Ries LAG, Kosary CL, Hankey BF, Miller BA, Harras A, Edwards BK (1998) Surveillance, Epidemiology, and End Results (SEER) program (web site). National Institutes of Health, Bethesda, MD. http://www-seer.ims.nci.nih.gov